Download Mobile App

Featured Video

AACC:
Are Antigens the Answer to Coronavirus Testing?

View Video

Recommended on TradeMed

visit trademed.com

Sedimentation Rate Analyzer
iSED

Hematology Analyzer
ACL TOP Family 50 Series

Chemiluminescence Analyzer
iFlash 1800

Partner Sites

HospiMedica

COVID-19 Infection Significantly Associated with Strokes, Find Researchers

Tesla Building Portable, Automated “RNA Microfactories” for CureVac's COVID-19 Vaccine

New Study Confirms COVID-19 Vaccine Will Need to Elicit T Cells to Work alongside Antibodies

Fujifilm’s AI Platform, REiLI Chosen by ASST Vimercate Hospital to Support Operators in Fight Against COVID-19

Pfizer and BioNTech Announce Early Positive Data from Phase 1/2 Study of mRNA-Based COVID-19 Vaccine Candidate

BioMedomics Launches COVID-19 IgM-IgG Rapid Test for Novel Coronavirus

By LabMedica International staff writers
Posted on 14 Mar 2020

Image: COVID-19 IgM-IgG Rapid Test (Photo courtesy of BioMedomics, Inc.)

BioMedomics, Inc. (Morrisville, NC, USA) has developed and launched one of the world’s first rapid point-of-care lateral flow immunoassays for the diagnosis of coronavirus infection. The new rapid IgM-IgG combined antibody test for COVID-19 is used to qualitatively detect IgG and IgM antibodies of the novel coronavirus in human serum, plasma or whole blood in vitro. These proteins indicate that a person’s immune system has responded to infection with the COVID-19 virus. It is one of the world’s first rapid tests for coronavirus utilizing this technology.

Recent studies suggest that a high percentage of patients show no clinical symptoms of the virus, which makes screening patients vitally important. The test can be used for rapid screening of carriers of the virus that are symptomatic or asymptomatic. By using biomarkers from the body’s immune response to COVID-19 instead of looking for the virus itself, the test can help determine if a person has been infected with COVID-19 even after the virus is no longer present. This information helps experts to better understand how the virus spreads through populations and develop strategies to prevent and slow the epidemic. The test is ideally suited for hospitals, clinics and test laboratories, and can also be effectively deployed in businesses, schools, airports, seaports and train stations, etc.

BioMedomics’ new rapid IgM-IgG combined antibody test for COVID-19 has been used widely by the Chinese CDC to combat infections and is now available globally. BioMedomics has also received CE Mark-IVD certification for the test which will allow it to be used to help diagnose patients in areas of Europe that have been impacted by the appearance of the COVID-19 pathogen.

“We are very proud to help fight this global epidemic,” said Dr. Frank Wang, CEO of BioMedomics. “Our team has been working hard to make this test a reality in the hope that it can help millions of people around the world by providing health experts with the information that they need to help treat and contain this new virus.”

Related Links:
BioMedomics, Inc.

Latest COVID-19 News

Channels

Clinical Chemistry

view channel

Image: Low levels of bicarbonate in the blood were linked to a higher risk of progression to chronic kidney disease (Photo courtesy of Blood Tests London).

Molecular Diagnostics

view channel

Image: The Chemagic 360 extracts DNA and uses transiently magnetized rods to attract the beads after binding to the nucleic acids (Photo courtesy of PerkinElmer).

Blood Group Locus Contributes to COVID-19 Severity Risk

There is considerable variation in disease behavior among patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19).... Read more

Image: Variability in prostate cancer–specific multigene panels; genetic testing registry as of August 2019 (Photo courtesy of Saud H. AlDubayan, MD).

Precision Medicine-Based Genetic Testing Developed for Prostate Cancer

Germline testing (GT) is a central feature of prostate cancer (PCA) treatment, management, and hereditary cancer assessment. Critical needs include optimized multigene testing strategies that incorporate... Read more

Image: This image depicts a DNA molecule that is methylated on both strands on the center cytosine. The two white spheres represent methyl groups (Photo courtesy of Wikimedia Commons)

Sensitive and Accurate Cancer Detection Through Analysis of Circulating Free DNA Methylation Patterns

An advanced liquid biopsy method for the detection and diagnosis of various types of cancer is based on the analysis of circulating tumor DNA methylation profiles. Definitive tumor diagnosis relies... Read more

$Image: Circulating tumor DNA (ctDNA) is found in serum and plasma fractions from blood. The mechanism of ctDNA release is unknown, though apoptosis, necrosis, and active secretion from tumor cells have been hypothesized. Once ctDNA is isolated, it can be sequenced for mutational analysis (Photo courtesy of Wikimedia Commons)$

Highly Sensitive Liquid Biopsy Technique Brings Personalized Cancer Monitoring a Step Closer

A modified liquid biopsy method enables detection of circulating tumor DNA (ctDNA) with much greater sensitivity than previously used techniques and demonstrates the potential to revolutionize all aspects... Read more

Hematology

view channel

Image: CAPILLARYS 2 FLEX PIERCING is an instrument utilizing capillary electrophoresis developed to be versatile while providing a clear-cut and precise protein separation with high throughput (Photo courtesy of Sebia).

Detection Rate of Monoclonal Gammopathy of Undetermined Significance Determined

Multiple myeloma (MM) is a clonal plasma cell malignancy that accounts for approximately 2% of all malignancies. Plasma cells help you fight infections by making antibodies that recognize and attack pathogens.... Read more

Image: The NanoDrop 2000 and 2000c are full-spectrum, UV-Vis spectrophotometers used to quantify and assess purity of DNA, RNA, Protein and more (Photo courtesy of Thermo Fisher Scientific).

Serum Mir‐22 Prognostic Marker Explored for Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is an aggressive hematopoietic stem cell malignancy that is characterized by the clonal proliferation of myeloid precursors. Abnormal accumulation of leukemic blasts in the... Read more

Tortuosity-Powered Microfluidic Device Assesses Thrombosis

Accurate assessment of blood thrombosis and antithrombotic therapy is essential for the management of patients in a variety of clinical conditions, including surgery and on extracorporeal life support.... Read more

Image: A unit of cord blood that can be used for stem cell transplants (Photo courtesy of Catholic University of Valencia).

Cord Blood Transplants May Outperform Matched Sibling Donors

When a cancer patient needs a bone marrow transplant, there are four common donor sources: A matched related donor (sibling), a matched unrelated donor (from a donor database), a half-matched donor, or... Read more

Immunology

view channel

Blood Test Could Predict Multiple Sclerosis Progression

Multiple sclerosis (MS) is an immune-mediated neurodegenerative disease of the central nervous system (CNS), with a highly variable inter-individual disease course. As a result, even if using existing... Read more

Diagnostic Assay Developed for Unclassified Severe Combined Immune Deficiency

Severe combined immune deficiency (SCID) is a group of rare hereditary genetic disorders, and is characterized by a total absence of immune system function, including an absence of T-lymphocytes, the white... Read more

Image: This illustration reveals ultrastructural morphology exhibited by coronaviruses. Note the spikes that adorn the outer surface of the virus, which impart the look of a corona surrounding the virion, when viewed electron microscopically (Photo courtesy of Centers for Disease Control and Prevention).

Certain Cytokines Not Associated with Severity of COVID-19 Symptoms

The pandemic outbreak of coronavirus disease 2019 (COVID-19) is sharply spreading all over the world. The severity of a viral disease usually is positive association with immune-mediated inflammatory responses.... Read more

Image: Schematic representation of the remote electrochemiluminescence (ECL) mechanism (Photo courtesy of University of Bologna).

Increasingly Efficient Serological Tests Developed with Electrochemiluminescence

Diagnostic markers, or biomarkers, are biomolecules (e.g., enzymes, proteins, peptides, and hormones) that can be measured accurately and reproducibly and can precisely predict relevant clinical outcomes... Read more

Microbiology

view channel

Image: The MiSeq Next Generation Sequencer is an integrated instrument that performs clonal amplification, genomic DNA sequencing, and data analysis with base calling, alignment, variant calling, and reporting in a single run (Photo courtesy of Illumina).

Gut Microbiome Dysbiosis Characterized in Parkinson’s Disease

Parkinson’s disease (PD) is a common, progressive, and debilitating disease, which currently cannot be prevented or cured. With the exception of rare genetic forms, the cause of PD is unknown.... Read more

Image: Corbett Rotor-Gene 6000 Real Time PCR Machine (Photo courtesy of Corbett Life Science).

Isothermal Amplification Method Used to Detect Salmonella Subtypes

Salmonella is a common cause of foodborne disease worldwide, including Australia. More than 85% of outbreaks of human salmonellosis in Australia were caused by five Salmonella serovars. Rapid, accurate,... Read more

Image: The Loa Antibody Rapid Test detects human IgG against a 148-aminoacid sequence of Ll-SXP-1 (Photo courtesy of Drugs & Diagnostics for Tropical Diseases).

Two Serodiagnostic Tests Compared for Loiasis in Non-Endemic Area

Loiasis, the disease caused by the infection with the filarial nematode Loa loa, is transmitted through the bite of tabanid flies of the genus Chrysops. It is endemic in Central and West Africa where,... Read more

Fidget Spinner Rapidly Detects Urinary Tract Infections

More than half of all women experience at least one episode of urinary tract infection (UTI) in their lifetime, with men also facing increasing risks of infection as they age. Current detection of UTIs... Read more

Pathology

view channel

Roche Advances Personalized Healthcare with Development of Image Analysis Algorithms Using Artificial Intelligence

Roche (Basel, Switzerland) has announced the CE-IVD launch of its automated digital pathology algorithm, the uPath PD-L1 (SP263) image analysis for non-small cell lung cancer (NSCLC). Roche is delivering... Read more

Image: Photomicrograph of pediatric pilocytic astrocytoma, a brain tumor, showing the characteristic bipolar cells with long hair-like processes (Photo courtesy of Nephron)

Precision Oncology Confers Clinical Benefit in Relapsed Pediatric Cancer

The Individualized Therapy for Relapsed Malignancies in Childhood (INFORM) registry has been created to help develop precision medicine-based approaches and to analyze their effectiveness across high-risk... Read more

Image: Schematic diagram of how the representative tumor sampling method lessens bias in molecular analyses (Photo courtesy of Francis Crick Institute).

Representative Tumor Sampling Method Lessens Molecular Analyses Bias

Over the past decade, clinical scientists have demonstrated the inability of an individual biopsy or formalin-fixed paraffin-embedded (FFPE) block to capture the genetic diversity of a solid tumor.... Read more

$Image: Schematic diagram of circulating tumor DNA (ctDNA) which is found in serum and plasma fractions from blood. The mechanism of ctDNA release is unknown, though apoptosis, necrosis, and active secretion from tumor cells have been hypothesized. Once ctDNA is isolated, it can be sequenced for mutational analysis (Photo courtesy of Rachel June Wong).$